Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saverio De Lorenzo

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Internal and Emergency Medicine|October 18, 2012
Tuberculosis a re-emerging diseaseSaverio De Lorenzo, Simon Tiberi
The European Respiratory Journal|August 31, 2013
Bedaquiline in MDR/XDR-TB cases: first experience on compassionate useSimon Tiberi, Saverio De Lorenzo, Rosella Centis, et al.
The European Respiratory Journal|November 7, 2015
Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
The European Respiratory Journal|November 21, 2015
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
Journal of Market Access & Health Policy|March 8, 2017
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in ItalyLuigi R Codecasa, Mondher Toumi, Anna D'Ausilio, et al.
The European Respiratory Journal|April 3, 2016
Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?Mathieu S Bolhuis, Simon Tiberi, Giovanni Sotgiu, et al.
The European Respiratory Journal|July 11, 2015
Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective studyMathieu S Bolhuis, Simon Tiberi, Giovanni Sotgiu, et al.
BMC Infectious Diseases|June 30, 2019
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference CentresNiccolò Riccardi, Riccardo Alagna, Laura Saderi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatmentGiovanni Battista Migliori, Giovanni Sotgiu, M D'Arcy Richardson, et al.
The European Respiratory Journal|September 22, 2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TBSaverio De Lorenzo, Jan Wilem Alffenaar, Giovanni Sotgiu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Internal and Emergency Medicine|October 18, 2012
Tuberculosis a re-emerging diseaseSaverio De Lorenzo, Simon Tiberi
The European Respiratory Journal|August 31, 2013
Bedaquiline in MDR/XDR-TB cases: first experience on compassionate useSimon Tiberi, Saverio De Lorenzo, Rosella Centis, et al.
The European Respiratory Journal|November 7, 2015
Tuberculosis elimination, patients' lives and rational use of new drugs: revisitedSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
The European Respiratory Journal|November 21, 2015
Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experienceSimon Tiberi, Lia D'Ambrosio, Saverio De Lorenzo, et al.
Journal of Market Access & Health Policy|March 8, 2017
Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in ItalyLuigi R Codecasa, Mondher Toumi, Anna D'Ausilio, et al.
The European Respiratory Journal|April 3, 2016
Is there still room for therapeutic drug monitoring of linezolid in patients with tuberculosis?Mathieu S Bolhuis, Simon Tiberi, Giovanni Sotgiu, et al.
The European Respiratory Journal|July 11, 2015
Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective studyMathieu S Bolhuis, Simon Tiberi, Giovanni Sotgiu, et al.
BMC Infectious Diseases|June 30, 2019
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference CentresNiccolò Riccardi, Riccardo Alagna, Laura Saderi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 23, 2009
Consensus not yet reached on key drugs for extensively drug-resistant tuberculosis treatmentGiovanni Battista Migliori, Giovanni Sotgiu, M D'Arcy Richardson, et al.
The European Respiratory Journal|September 22, 2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TBSaverio De Lorenzo, Jan Wilem Alffenaar, Giovanni Sotgiu, et al.
Pageof 2